1 Min Read
July 12 (Reuters) - Aurinia Pharmaceuticals Inc
* Aurinia resolves temporary non-compliance with Nasdaq’s audit committee composition rule Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.